ELTHORNE PARK SURGERY — All Prescriptions & Medications — Page 9
Practice Code: E85628 | LONDON, W7 2JJ
Showing results 401-450 of 482
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Exemestane | 16 | 1,230 | £182 | -50.8% ▼ |
| 16 | 280 | £127 | -62.9% ▼ | |
| 16 | 880 | £218 | +8.7% ▲ | |
| Phosphates (Rectal) | 15 | 118 | £385 | +22.7% ▲ |
| Hydroxyzine hydrochloride | 15 | 448 | £13 | -71.8% ▼ |
| Hyoscine hydrobromide | 15 | 1,232 | £199 | -56.1% ▼ |
| Frovatriptan | 15 | 162 | £407 | +6.1% ▲ |
| Ethosuximide | 15 | 3,408 | £3.9K | +1.7% vs avg |
| Metronidazole | 15 | 377 | £79 | -77.2% ▼ |
| Betamethasone sodium phosphate | 15 | 1,062 | £138 | +22.0% ▲ |
| Fluorometholone | 15 | 250 | £72 | +4.1% ▲ |
| 15 | 16 | £18 | -43.3% ▼ | |
| Labetalol hydrochloride | 14 | 1,008 | £76 | -38.3% ▼ |
| Perindopril arginine | 14 | 1,080 | £233 | +18.4% ▲ |
| Modafinil | 14 | 1,184 | £187 | -32.9% ▼ |
| Domperidone | 14 | 1,059 | £23 | -60.7% ▼ |
| Empagliflozin/metformin | 14 | 1,232 | £765 | -73.1% ▼ |
| Liquid OTC glucose for diabetic hypo treatment (0913541) | 14 | 9,420 | £147 | -38.9% ▼ |
| Celecoxib | 14 | 766 | £277 | -78.8% ▼ |
| Betamethasone sodium phosphate | 14 | 160 | £35 | -46.0% ▼ |
| Prednisolone sodium phosphate | 14 | 340 | £180 | +9.8% ▲ |
| Travoprost | 14 | 88 | £55 | -70.3% ▼ |
| Ciprofloxain/dexameth | 14 | 75 | £87 | -54.4% ▼ |
| Zinc oxide | 14 | 10.7K | £297 | -30.4% ▼ |
| Other sunscreening preparations | 14 | 1,750 | £133 | +78.6% ▲ |
| Hydrocortisone | 13 | 407 | £99 | -82.9% ▼ |
| Bempedoic acid | 13 | 532 | £1.0K | -60.3% ▼ |
| Ephedrine hydrochloride | 13 | 1,820 | £8.1K | +74.0% ▲ |
| Theophylline | 13 | 1,022 | £517 | -84.5% ▼ |
| Aclidinium bromide/formoterol | 13 | 23 | £710 | -63.0% ▼ |
| Desloratadine | 13 | 810 | £66 | -54.9% ▼ |
| Tapentadol | 13 | 728 | £972 | -68.4% ▼ |
| Nicotine | 13 | 259 | £399 | -77.0% ▼ |
| Heparinoid | 13 | 1,625 | £89 | -50.4% ▼ |
| Dexamethasone sodium metasulphobenzoate | 13 | 120 | £107 | +74.9% ▲ |
| 13 | 13 | £30 | -59.9% ▼ | |
| 13 | 860 | £1.7K | -73.3% ▼ | |
| 13 | 640 | £453 | -60.7% ▼ | |
| 13 | 1,300 | £187 | -59.1% ▼ | |
| 13 | 1,170 | £5.8K | +2.8% ▲ | |
| Glyceryl trinitrate | 12 | 390 | £485 | -9.7% ▼ |
| Dronedarone hydrochloride | 12 | 720 | £812 | -16.9% ▼ |
| Irbesartan with diuretic | 12 | 672 | £185 | -23.7% ▼ |
| Terbutaline sulphate | 12 | 17 | £134 | -77.9% ▼ |
| Indacaterol/glycopyrronium | 12 | 690 | £710 | -73.4% ▼ |
| Naratriptan hydrochloride | 12 | 144 | £28 | -54.1% ▼ |
| Rizatriptan | 12 | 141 | £490 | -79.8% ▼ |
| Eslicarbazepine acetate | 12 | 1,080 | £2.3K | -46.2% ▼ |
| Erythromycin | 12 | 892 | £361 | -65.4% ▼ |
| Dexamethasone | 12 | 357 | £64 | -61.5% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.